Haihe Lab–incubated firm Tiankai Suishi received a national Class II medical
device registration certificate from the Tianjin Municipal Medical Products
Administration for its EEG signal acquisition and cognitive function assessment
system (Shengong–Shengao). The approval is China's first BCI-related product for
assisted diagnosis of cognitive impairment and allows the device to enter scaled
clinical use.
